Skip to content

Fundamental Processes Short Notes

One-page CSIR NET revision for Unit 3: replication, repair, recombination, transcription, RNA processing, translation, protein fate and gene regulation.

  • 9 min read
  • Updated
On this page · 8 sections
  1. Replication
  2. Repair and Recombination
  3. Transcription and RNA Processing
  4. Translation and Protein Fate
  5. Gene Regulation and Epigenetics
  6. Classic Experiments (Part C favourites)
  7. Ten-Second Formula Card
  8. What’s Next

The whole of Unit 3 on one page. For explanations and worked problems, go back to the chapter: DNA Replication, Repair and Recombination, Transcription, RNA Processing and Non-coding RNA, Translation, Protein Processing and Degradation and Regulation of Gene Expression and Epigenetics.

Replication

FactDetail
ModeSemi-conservative (Meselson–Stahl 1958): generation 1 one hybrid band; generation n: 2 hybrid of 2ⁿ
Polymerase rulesTemplate + primer 3’-OH; 5’ → 3’ only; leading continuous, lagging in Okazaki fragments
Okazaki fragments1,000–2,000 nt (bacteria); 100–200 nt (eukaryotes)
oriCDnaA boxes, AT-rich 13-mers, GATC; DnaA-ATP initiator
Re-initiation blockSeqA (hemimethylated oriC), RIDA (Hda, DnaA-ATP → ADP)
Fork proteinsDnaB helicase (5’ → 3’), DnaC loader, DnaG primase, SSB, gyrase (quinolones on GyrA, novobiocin on GyrB)
Pol IIIα polymerase; ε 3’ → 5’ exo; β-clamp; γ/τ clamp loader; ~1,000 nt s⁻¹ per fork
Pol I5’ → 3’ exo removes primers; Klenow lacks it; polA mutants still replicate
LigaseNAD⁺ (E. coli), ATP (eukaryotes, T4)
TerminationTer–Tus fork traps; topo IV decatenates; XerCD at dif
Eukaryotic licensingORC + Cdc6 + Cdt1 → MCM2–7 in G1; CDK + DDK → CMG (Cdc45–MCM–GINS) in S; geminin
Eukaryotic polymerasesα-primase (no proofreading), ε leading, δ lagging, PCNA/RFC, FEN1 + RNase H, ligase I
Other polymerasesβ (BER), γ (mito), η (TLS past T-T; XP-V), Pol IV/V (SOS)
TelomeraseTERT + RNA template; reverse transcriptase; TTAGGG; shelterin
FidelitySelection 10⁻⁴–10⁻⁵ → proofreading ×100 → MMR ×100–1,000 → 10⁻⁹–10⁻¹⁰
MutatorsmutD (dnaQ), mutS, mutL, mutH, dam
PlasmidsColE1: RNA II primer, RNA I antisense, Rop; pUC lacks rop; rolling circle (φX174, M13, F transfer); incompatibility
mtDNA16,569 bp (human); Pol γ; D-loop

Repair and Recombination

FactDetail
Direct reversalPhotolyase (light, FADH⁻; absent in placental mammals); MGMT/Ada (suicide, O⁶-meG); AlkB
BERGlycosylase (UNG, OGG1, MUTYH) → APE1 → Pol β (dRP lyase) → ligase III/XRCC1
Why T, not UDeaminated C (U) is recognisable; 5mC → T makes CpG hotspots
NER (E. coli)UvrA₂B detect, UvrC cuts, 12–13 nt removed, UvrD, Pol I, ligase
NER (human)XPC (global), CSA/CSB (transcription-coupled), TFIIH (XPB, XPD), XPA, XPG (3’), XPF–ERCC1 (5’); ~30 nt
MMRMutS → MutL → MutH nicks unmethylated GATC strand → UvrD + exo → Pol III; MSH2/MLH1, Lynch syndrome
DSB repairHR (MRN, resection, RPA, BRCA2, Rad51; S/G2, accurate) vs NHEJ (Ku70/80, DNA-PKcs, Artemis, ligase IV; error-prone; V(D)J)
CheckpointATM → γH2AX (Ser139); ATR at RPA–ssDNA
SOSRecA* → LexA autocleavage; UmuD → UmuD’; Pol V error-prone TLS; also cleaves λ cI
HR proteinsRecBCD (Chi 5’-GCTGGTGG-3’), RecA, RuvAB (branch migration), RuvC (resolvase); Rad51, Dmc1, Spo11
ModelsHolliday junction; DSBR (double HJ); SDSA (non-crossover)
Gene conversionMMR of heteroduplex → 3:1 (6:2); post-meiotic segregation 5:3
Site-specificTyr (Cre, λ Int, FLP, XerCD; HJ intermediate) vs Ser (Hin, resolvases; all strands cut)
Site orientationDirect → excision; inverted → inversion; two molecules → integration
loxP34 bp = 13 + 8 (spacer) + 13
λIntegration Int + IHF; excision Int + IHF + Xis
TranspositionCut-and-paste (Tn5, Tn10, Ac/Ds, P); replicative (Tn3, Mu); retrotransposons (Ty1, copia, LINE-1, Alu); target-site duplication

Transcription and RNA Processing

FactDetail
E. coli RNAPCore α₂ββ’ω + σ
σ⁷⁰ promoter−35 TTGACA, −10 TATAAT, 17 bp spacer; UP element (αCTD)
Other σσ³² heat shock; σ⁵⁴ (needs ATPase enhancer-binding activator); σˢ stationary; σ²⁸ flagella; σᴱ envelope
TerminationIntrinsic: GC hairpin + U-run; Rho: rut site, hexameric ATPase helicase
InhibitorsRifampicin (β, initiation); streptolydigin (elongation); actinomycin D (DNA, all); α-amanitin (Pol II > III > I); cordycepin; DRB, flavopiridol (CDK9); triptolide (XPB)
Pol I / II / IIIrRNA (18S, 5.8S, 28S) / mRNA, miRNA, U1, U2, U4, U5 / tRNA, 5S, U6, 7SL
GTFsTFIID (TBP + TAFs) → IIA → IIB → Pol II/IIF → IIE → IIH (XPB, CDK7)
CTDYSPTSPS; Ser5-P (CDK7, capping) → Ser2-P (CDK9/P-TEFb, elongation, 3’ end)
ActivatorsDBD + AD (modular; Gal4 swaps, two-hybrid); Mediator; HATs, remodellers
CapTriphosphatase, guanylyltransferase, N7-MTase (SAM); m⁷GpppN; CBC then eIF4E
Splicing5’ GU … branch A … Py … AG 3’; 2 transesterifications; lariat 2’–5’
snRNPsU1 5’ ss; U2 branch; U4/U6·U5; U6 replaces U1; U2–U6 catalytic; minor U11/U12
Self-splicingGroup I exogenous G, linear; group II branch A, lariat
Alternative splicingSR proteins (enhancers), hnRNPs (silencers); Sxl–Tra–Dsx; Dscam
NMDPTC >50–55 nt upstream of last exon junction; EJC, UPF1
EditingapoB C→U (APOBEC1) → stop → apoB-48 (intestine); ADAR A→I (GluA2 Q/R); trypanosome U insertion/deletion
Poly(A)AAUAAA (CPSF) 10–30 nt upstream; GU-rich (CstF); PAP; PABPN1; histone mRNAs: stem-loop + SLBP
DecayDeadenylation → decapping → Xrn1; exosome; AU-rich elements
rRNA/tRNARNase III (bacteria); snoRNAs C/D (2’-O-Me), H/ACA (Ψ); RNase P (ribozyme), CCA addition
ExportmRNA NXF1–NXT1 (TREX; Ran-independent); tRNA exportin-t; pre-miRNA exportin-5; CRM1 (NES, HIV Rev–RRE)
RibozymesGroup I/II, RNase P, hammerhead/hairpin/HDV, rRNA peptidyl transferase, spliceosome, glmS; Cech and Altman (Nobel 1989)
RiboswitchesAptamer + expression platform; TPP, FMN, SAM, Lys, Gly, purines; terminator or SD control
miRNADrosha–DGCR8 → exportin-5 → Dicer → AGO/RISC; seed 2–8; repression + decay
siRNA / piRNAsiRNA: perfect pairing, AGO2 slicing; piRNA: Dicer-independent, PIWI, germline transposons
lncRNAXist, HOTAIR, 7SK, MALAT1, NEAT1
Bacterial ncRNAsRNAs + Hfq (RyhB, MicF); 6S RNA; tmRNA; crRNA

Translation and Protein Fate

FactDetail
Code61 sense + UAA, UAG, UGA; mito UGA = Trp; Sec at UGA + SECIS
WobbleAnticodon 34: G pairs C/U; U pairs A/G; I pairs U/C/A; minimum about 32 tRNAs
aaRSaa-AMP intermediate, 2 ~P; class I 2’-OH (Rossmann), class II 3’-OH; editing site
Ribosomes70S = 30S (16S) + 50S (23S, 5S); 80S = 40S (18S) + 60S (28S, 5.8S, 5S)
SitesA, P, E; decoding centre 16S; peptidyl transferase = 23S rRNA
Bacterial initiationSD–anti-SD (16S 3’ end); IF1, IF2·GTP, IF3; fMet (N¹⁰-formyl-THF)
Eukaryotic initiationeIF4F (4E, 4G, 4A) on cap; 43S scanning; Kozak: A/G at −3, G at +4; eIF2·GTP·Met-tRNAᵢ; eIF2B GEF; eIF5B; IRES
ElongationEF-Tu (eEF1A) + EF-Ts; rRNA peptide bond; EF-G (eEF2); N → C; ≥4 ~P per bond
TerminationRF1 UAA/UAG; RF2 UAA/UGA; RF3; eRF1 all three, eRF3; GGQ; RRF; tmRNA
Inhibitors (30S)Streptomycin (misreading), kanamycin, gentamicin, tetracycline (A site)
Inhibitors (50S)Chloramphenicol (PTC; also mito), erythromycin (tunnel), linezolid; fusidic acid (EF-G), kirromycin (EF-Tu)
Inhibitors (all / 80S)Puromycin (all; A-site analogue); cycloheximide (80S E site); diphtheria toxin (eEF2 ADP-ribosylation); ricin (28S depurination)
Translational controleIF2α-P (HRI, PKR, PERK, GCN2) ⊣ eIF2B → ATF4/GCN4 up; mTORC1 ⊣ 4E-BP; IRE/IRP (ferritin 5’ block; TfR 3’ stabilise); miRNAs; RF2 +1 frameshift
N-glycosylationAsn-X-Ser/Thr; OST in ER; dolichol-PP; tunicamycin; calnexin cycle
Lipid anchorsMyristoyl (N-Gly), palmitoyl (Cys, reversible), prenyl (CaaX), GPI
Other PTMsPhosphorylation, acetylation, methylation, disulfide (PDI), hydroxylation (vitamin C), γ-carboxylation (vitamin K), proinsulin → insulin + C-peptide
ER entrySignal → SRP (7SL RNA, SRP54; pauses translation) → SR (GTPases) → Sec61; signal peptidase; stop-transfer, signal-anchor
SignalsKDEL (ER), M6P (lysosome; I-cell disease), NLS (PKKKRKV; importin, Ran), NES (CRM1), presequence (TOM/TIM23, Δψ, MPP), SKL (Pex5, folded import), transit peptide (TOC/TIC)
CoatsCOPII (ER → Golgi, Sar1); COPI (retrograde, ARF1); clathrin (TGN, endocytosis, dynamin); Rab, SNAREs, NSF
Bacterial exportSec (SecA, SecYEG), SRP (Ffh, 4.5S RNA), Tat (folded)
UPRIRE1 (XBP1 splicing), PERK (eIF2α), ATF6 (Golgi cleavage); ERAD
Ubiquitin76 aa; E1 (ATP) → E2 → E3 (RING, HECT; SCF, APC/C); K48 → proteasome; K63 signalling
Proteasome26S = 20S (α₇β₇β₇α₇) + 19S; β1 caspase-like, β2 trypsin-like, β5 chymotrypsin-like; N-terminal Thr; bortezomib
DegronsN-end rule (Ubr1), PEST, phosphodegron, D-box, HIF Pro-OH → VHL
AutophagymTORC1 ⊣ ULK1; LC3-II; p62; CMA: KFERQ, Hsc70, LAMP-2A

Gene Regulation and Epigenetics

FactDetail
lacLacI tetramer; allolactose (IPTG gratuitous); cAMP–CAP when glucose low; inducer exclusion
lac mutantsI⁻ recessive constitutive; Iˢ dominant non-inducible; I⁻ᵈ dominant constitutive; Oᶜ cis-dominant constitutive; P⁻ cis
trpTrpR + Trp; attenuation: 14-aa leader, 2 Trp codons; high Trp → 3–4 terminator; low Trp → 2–3 antiterminator
araAraC: O₂–I₁ loop represses; arabinose → I₁–I₂ + CAP activates P_BAD
Other bacterialσ cascades (sporulation σᶠ/σᴱ/σᴳ/σᴷ); two-component (His-kinase → Asp); LuxI/LuxR; RelA → (p)ppGpp
λ repressorcI: O_R1 > O_R2 (activates P_RM) > O_R3
λ CroO_R3 first → represses P_RM
λ decisionCII (FtsH-degraded; CIII protects) → P_RE, P_I, P_aQ → lysogeny; N, Q antiterminators
λ mutantscI⁻/cII⁻/cIII⁻ clear plaques; λ vir (operators); cI857 (heat-inducible); immunity is repressor–operator specific
PhagesT7: own single-subunit RNAP; T4: MotA/AsiA, gp55 σ
VirusesHIV Tat–TAR–P-TEFb; Rev–RRE–CRM1; SV40 large T; adenovirus E1A; HSV VP16
Eukaryotic controlEnhancers, silencers, insulators (CTCF), LCR, Mediator, loops/TADs; combinatorial
GALGal4 (UAS_G), Gal80 masks AD, galactose–Gal3 sequesters Gal80; glucose represses
Nuclear receptorsSteroid receptors + Hsp90 (cytoplasm) → HRE; TR–RXR represses without ligand
Nucleosome147 bp, octamer (H2A, H2B, H3, H4)₂; H1
RemodellersSWI/SNF, ISWI, CHD, INO80/SWR1 (H2A.Z)
Active marksH3K4me3 (promoter), H3K36me3 (body), H3K27ac, H3K4me1 (enhancers), H4K16ac
Silent marksH3K9me3 (SUV39H1 → HP1), H3K27me3 (PRC2/EZH2 → PRC1, H2AK119ub1)
ErasersHDACs (TSA, butyrate); sirtuins (NAD⁺); LSD1 (FAD); JmjC (Fe²⁺, α-KG)
VariantsH2A.Z, H3.3, CENP-A, macroH2A, γH2AX
DNA methylationCpG; DNMT1 + UHRF1 maintenance; DNMT3A/B de novo; MeCP2/MBD; TET → 5hmC → 5fC → 5caC
AssaysBisulfite: unmethylated C → T; 5mC stays C; HpaII blocked by CmCGG, MspI not
SilencingSir2/3/4 (budding yeast HM loci, telomeres); RITS–Clr4–Swi6 (fission yeast); PEV (Su(var)); RdDM (plants); piRNA
Dosage compensationMammals: Xist (Tsix), random X-inactivation (imprinted in marsupials, mouse extra-embryonic); fly: male X ×2 (MSL, H4K16ac); worm: XX ÷2
ImprintingIgf2/H19: maternal ICR unmethylated + CTCF → H19; paternal methylated → Igf2
DisordersPrader–Willi (paternal 15q11–q13 loss); Angelman (maternal UBE3A loss)

Classic Experiments (Part C favourites)

ExperimentShowed
Meselson–Stahl (¹⁵N/¹⁴N, CsCl)Semi-conservative replication
Okazaki pulse-labellingDiscontinuous lagging-strand synthesis
polA mutant viabilityPol I is not the main replicase
Cys-tRNA → Ala-tRNACysRibosome reads the tRNA, not the amino acid
α-Amanitin titration of nucleiThree distinct nuclear RNA polymerases
Tetrahymena intron, RNase PRNA can catalyse (ribozymes)
Puromycin reactionP-site peptidyl-tRNA; translocation
Signal-sequence fusions and SRPSignal hypothesis
lac merodiploids (Jacob and Monod)Operator cis, repressor trans
trp leader mutations (Yanofsky)Attenuation via coupled translation
λ clear-plaque and vir mutantsRepressor–operator control of lysogeny
Fire and Mello (dsRNA in C. elegans)RNA interference
HpaII/MspI and bisulfiteCpG methylation mapping

Ten-Second Formula Card

$$\text{hybrid fraction after } n \text{ generations} = \frac{2}{2^n}\ (n \ge 1) \qquad t_{\text{replication}} = \frac{\text{genome length}/2}{\text{fork speed}}$$$$\text{origins}_{\min} = \frac{\text{chromosome length}}{2 \times \text{fork speed} \times t_S} \qquad \text{errors per replication} = N \times \varepsilon_{\text{insert}} \times f_{\text{proofread}} \times f_{\text{MMR}}$$$$\text{high-energy bonds per peptide bond} \ge 4 \qquad \text{ribosomes per mRNA} = \frac{\text{time to translate}}{\text{initiation interval}} \qquad t_{1/2} = \frac{0.693}{k}$$

What’s Next

Advertisement
Advertisement